데이터가 없습니다.

1. Serum zinc deficiency is a potential risk factor for the occurrence of levodopa-induced dyskinesia in drug-naive Parkinson's disease [ Frontiers in Aging Neuroscience ] - 2023.11.02
2. Serum zinc deficiency could be associated with dementia conversion in Parkinson's disease [ Frontiers in Aging Neuroscience ] - 2023.04.27
3. Cardiac sympathetic denervation could be associated with dysphagia in Parkinson's disease [ Frontiers in Neurology ] - 2022.10.11
4. Anodal Transcranial Direct Current Stimulation Could Modulate Cortical Excitability and the Central Cholinergic System in Akinetic Rigid-Type Parkinson's Disease: Pilot Study [ Frontiers in Neurology ] - 2022.03.24
5. Intrasubject relationship between striatal F-18-FP-CIT uptake and cardiac I-123-MIBG uptake differs by motor subtype in early Parkinson disease [ MEDICINE ] - 2021.08.01
6. Gastrectomy, vitamin B12 supplementation and the risk of Parkinson ? s disease: A nationwide cohort study [ PARKINSONISM & RELATED DISORDERS ] - 2021.02.01
7. Timed Up and Go Test and the Risk of Parkinson's Disease: A Nation-wide Retrospective Cohort Study [ MOVEMENT DISORDERS ] - 2020.07.01
8. Body mass index, diabetes, and the risk of Parkinson's disease [ MOVEMENT DISORDERS ] - 2020.02.01
9. Neuroprotective effect of anodal transcranial direct current stimulation on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity in mice through modulating mitochondrial dynamics [ NEUROCHEMISTRY INTERNATIONAL ] - 2019.10.01
10. Association of statin use with Parkinson's disease: Dose-response relationship [ MOVEMENT DISORDERS ] - 2019.07.01
11. Genetic variants of PARK genes in Korean patients with early-onset Parkinson's disease [ NEUROBIOLOGY OF AGING ] - 2019.03.01
12. Cerebrospinal Fluid Levels of Autophagy-related Proteins Represent Potentially Novel Biomarkers of Early-Stage Parkinson's Disease [ SCIENTIFIC REPORTS ] - 2018.11.15
13. Serum 25-hydroxyvitamin D3 level may be associated with olfactory dysfunction in de novo Parkinson's disease [ JOURNAL OF CLINICAL NEUROSCIENCE ] - 2018.11.01
14. Anodal transcranial direct current stimulation prevents methyl-4phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity by modulating autophagy in an in vivo mouse model of Parkinson's disease [ SCIENTIFIC REPORTS ] - 2018.10.11
15. Olfactory dysfunction in early Parkinson's disease is associated with short latency afferent inhibition reflecting central cholinergic dysfunction. [ CLINICAL NEUROPHYSIOLOGY ] - 2017.06.01
16. Autophagic modulation by rosuvastatin prevents rotenone-induced neurotoxicity in an in vitro model of Parkinson's disease [ NEUROSCIENCE LETTERS ] - 2017.03.06
17. Public Awareness and Knowledge about Parkinson's Disease: A National Population Based Survey in South Korea [ NEUROEPIDEMIOLOGY ] - 2016.11.04
18. Vitamin D receptor polymorphisms and Parkinson's disease in a Korean population: Revisited [ NEUROSCIENCE LETTERS ] - 2016.08.15
19. The Neuroprotective Effect of Erythropoietin on Rotenone-Induced Neurotoxicity in SH-SY5Y Cells Through the Induction of Autophagy [ MOLECULAR NEUROBIOLOGY ] - 2016.08.01
20. Low Serum Vitamin D Levels May Contribute to Gastric Dysmotility in de novo Parkinson's Disease [ NEURODEGENERATIVE DISEASES ] - 2016.04.01
21. Central cholinergic dysfunction could be associated with oropharyngeal dysphagia in early Parkinson's disease [ JOURNAL OF NEURAL TRANSMISSION ] - 2015.11.01
22. Vitamin D deficiency in Parkinson's disease patients with orthostatic hypotension. [ ACTA NEUROLOGICA SCANDINAVICA ] - 2015.10.01
23. Biochemical protective effect of 1,25-dihydroxyvitamin D3 through autophagy induction in the MPTP mouse model of Parkinson's disease. [ NEUROREPORT ] - 2015.08.19
24. 1,25-dyhydroxyvitamin D3 attenuates L-DOPA-induced neurotoxicity in neural stem cells. [ Molecular Neurodegeneration ] - 2015.04.01
25. Triple stimulation technique findings in vascular Parkinsonism and Parkinson’s disease [ CLINICAL NEUROPHYSIOLOGY ] - 2014.09.01
26. 1,25-Dyhydroxyvitamin D₃ attenuates rotenone-induced neurotoxicity in SH-SY5Y cells through induction of autophagy. [ BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS ] - 2014.08.15
27. Safety and efficacy of recombinant human erythropoietin treatment of non-motor symptoms in Parkinson's disease [ JOURNAL OF THE NEUROLOGICAL SCIENCES ] - 2014.02.15

1. 한국어판 국제 실조 평가 척도의 신뢰도 및 타당도 검정 - 2021.06.01 ~ 2022.02.28
2. 파킨슨병 환자에서의 경두개직류자극의 뇌척수액 대사체 연구 - 2020.07.01 ~ 2021.06.30
3. 파킨슨병의 레보도파 유발 이상운동증 모델에서의 경두개직류자극 적용의 효과 - 2019.03.01 ~ 2021.02.28
4. 경두개 직류 자극에 의한 유전자 변이 파킨슨병 모델 마우스의 microRNA연구 - 2019.03.01 ~ 2022.02.28
5. 혈액 전사체의 파킨슨병에서의 생체표지자로서의 가능성에 대한 연구 - 2019.01.01 ~ 2020.06.30
6. 파킨슨병환자의아형분류를위한뇌척수액에서의microRNA의프로파일링 - 2018.07.16 ~ 2019.07.15
7. MPTP로 유도된 파킨슨병 쥐모델에서 경두개직류자극을 사용한 미토콘드리아 보호기전을 통한 신경보호효과 - 2018.05.01 ~ 2019.11.30
8. 한국 내 조발성 파킨슨병 환자의 유전자 변이 발견을 위한 유전자 패널 연구 - 2017.03.01 ~ 2019.02.28
9. Choline alfoscerate 의 유전자변이쥐를 통한 파킨슨병 생체모델에 있어서의 신경보호효과 - 2017.02.01 ~ 2019.12.17
10. 유전자 형질변형 마우스를 이용한 파킨슨모델에서의 신경보호치료개발 - 2016.11.07 ~ 2017.11.06
11. Chloramphenicol의 autophagy modulation을 통한 파킨슨병 in vitro model에 대한 신경 보호 효과 - 2016.04.01 ~ 2018.12.31
12. Statin(Rosuvastatin)의 autophagy기전 modulation을 통한 파킨슨병 in vitro model에 대한 신경 보호 효과 - 2015.07.22 ~ 2016.06.30
13. 경두개 직진전류 자극의 파킨슨병 모델에 있어서의 신경보호효과 - 2015.07.07 ~ 2015.07.06
14. 한국의 인구집단에서의 일반인들의 파킨슨병에 대한 인식도 조사 - 2015.06.01 ~ 2017.05.31
15. Erythropoietin의 autophagy 기전을 통한 파킨슨병 in vitro medel에 대한 신경 보호 효과 - 2015.03.05 ~ 2016.03.05

데이터가 없습니다.

      데이터가 없습니다.

 공지